Carcinoid Valvulopathy and Related Conditions

Overview

About this study

The objective of this study is to aid research into the immunologic basis of carcinoid valvulopathy and related conditions. By collecting prospective patient samples associated with carcinoid tissue database will allow researchers to study a variety of questions related to these diseases. Our hypothesis is that unique inflammatory signatures and populations are the underlying basis for these conditions, and we will use a number of cutting-edge technologies to define these populations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with diagnosed or suspected inflammatory heart disease.

Exclusion Criteria: 

  • Patients without diagnosed or suspected inflammatory heart disease.


Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/06/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joseph Maleszewski, M.D.

Open for enrollment

Contact information:

Ginno Huarocc M.H.A.

(507) 293-9690

Huarocc.Ginno@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20582214

Mayo Clinic Footer